Biochemical Recurrence After Radical Prostatectomy: Multiplicative Interaction Between Surgical Margin Status and Pathological Stage

  • Lars Budäus
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Hendrik Isbarn
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Christian Eichelberg
    Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Giovanni Lughezzani
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
  • Maxine Sun
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
  • Paul Perrotte
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
  • Felix K.H. Chun
    Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Georg Salomon
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Thomas Steuber
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Jens Köllermann
    Department of Pathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Guido Sauter
    Department of Pathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Sascha A. Ahyai
    Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Mario Zacharias
    Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Margit Fisch
    Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • Thorsten Schlomm
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Alexander Haese
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Hans Heinzer
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Hartwig Huland
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Francesco Montorsi
    Department of Urology, Vita-Salute San Raffaele University, Milan, Italy
  • Markus Graefen
    Martiniclinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
  • Pierre I. Karakiewicz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada

収録刊行物

  • Journal of Urology

    Journal of Urology 184 (4), 1341-1346, 2010-10

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

キーワード

問題の指摘

ページトップへ